CD274 and neoplasm: TCTP inhibition with DHA sensitizes tumors to T cell-mediated therapy, including anti-PD-L1 and ACT therapy, by increasing tumor-reactive T cells in the tumor and the CTL-mediated lysis of tumor cells.